Omalizumab treats multi-food allergy better than oral immunotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 5-May-2025 11:09 ET (5-May-2025 15:09 GMT/UTC)
The high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial explained the superiority of omalizumab.